Total Payments
$331,193
2024 Payments
$95,938
Companies
19
Transactions
728
Payment Breakdown by Category
Other$249,583 (75.4%)
Travel$54,872 (16.6%)
Consulting$13,520 (4.1%)
Food & Beverage$13,219 (4.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $249,583 | 175 | 75.4% |
| Travel and Lodging | $54,872 | 269 | 16.6% |
| Consulting Fee | $13,520 | 5 | 4.1% |
| Food and Beverage | $13,219 | 279 | 4.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $284,279 | 546 | $0 (2024) |
| Ferring Pharmaceuticals Inc. | $37,069 | 92 | $0 (2018) |
| PFIZER INC. | $8,216 | 15 | $0 (2024) |
| Novo Nordisk Inc | $406.39 | 22 | $0 (2024) |
| ABBVIE INC. | $327.59 | 2 | $0 (2023) |
| Lilly USA, LLC | $194.89 | 10 | $0 (2023) |
| Amarin Pharma Inc. | $137.32 | 3 | $0 (2020) |
| Kowa Pharmaceuticals America, Inc. | $117.66 | 9 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $74.89 | 5 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $72.53 | 6 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $95,938 | 186 | Amgen Inc. ($95,782) |
| 2023 | $65,888 | 114 | Amgen Inc. ($58,614) |
| 2022 | $78,969 | 166 | Amgen Inc. ($77,801) |
| 2021 | $52,161 | 120 | Amgen Inc. ($51,998) |
| 2020 | $315.65 | 15 | Novo Nordisk Inc ($175.57) |
| 2019 | $459.32 | 13 | AbbVie, Inc. ($300.00) |
| 2018 | $31,446 | 88 | Ferring Pharmaceuticals Inc. ($31,236) |
| 2017 | $6,015 | 26 | Ferring Pharmaceuticals Inc. ($5,833) |
All Payment Transactions
728 individual payment records from CMS Open Payments — Page 1 of 30
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | Amgen Inc. | Otezla (Drug) | Travel and Lodging | Cash or cash equivalent | $28.14 | General |
| Category: Inflammation | ||||||
| 12/26/2024 | Amgen Inc. | Otezla (Drug) | Travel and Lodging | Cash or cash equivalent | $28.14 | General |
| Category: Inflammation | ||||||
| 12/03/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $20.93 | General |
| Category: Cardiovascular | ||||||
| 11/19/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $21.15 | General |
| Category: Cardiovascular | ||||||
| 11/05/2024 | Amgen Inc. | Otezla (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,100.00 | General |
| Category: Inflammation | ||||||
| 11/05/2024 | Amgen Inc. | Otezla (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $700.00 | General |
| Category: Inflammation | ||||||
| 11/01/2024 | Amgen Inc. | Otezla (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,100.00 | General |
| Category: Inflammation | ||||||
| 11/01/2024 | Amgen Inc. | Otezla (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $350.00 | General |
| Category: Inflammation | ||||||
| 10/30/2024 | Amgen Inc. | Otezla (Drug) | Travel and Lodging | In-kind items and services | $155.17 | General |
| Category: Inflammation | ||||||
| 10/29/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $111.30 | General |
| Category: Inflammation | ||||||
| 10/25/2024 | Amgen Inc. | Otezla (Drug) | Travel and Lodging | In-kind items and services | $156.27 | General |
| Category: Inflammation | ||||||
| 10/24/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Inflammation | ||||||
| 10/21/2024 | Amgen Inc. | Otezla (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,750.00 | General |
| Category: Inflammation | ||||||
| 10/18/2024 | Amgen Inc. | Otezla (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,100.00 | General |
| Category: Inflammation | ||||||
| 10/18/2024 | Amgen Inc. | Otezla (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $350.00 | General |
| Category: Inflammation | ||||||
| 10/14/2024 | Amgen Inc. | Otezla (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,100.00 | General |
| Category: Inflammation | ||||||
| 10/14/2024 | Amgen Inc. | Otezla (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,100.00 | General |
| Category: Inflammation | ||||||
| 10/14/2024 | Amgen Inc. | Otezla (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,100.00 | General |
| Category: Inflammation | ||||||
| 10/14/2024 | Amgen Inc. | Otezla (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $700.00 | General |
| Category: Inflammation | ||||||
| 10/09/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: Oncology | ||||||
| 10/04/2024 | Amgen Inc. | Otezla (Drug) | Travel and Lodging | In-kind items and services | $373.95 | General |
| Category: Inflammation | ||||||
| 10/04/2024 | Amgen Inc. | Otezla (Drug) | Travel and Lodging | In-kind items and services | $241.50 | General |
| Category: Inflammation | ||||||
| 10/03/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $124.74 | General |
| Category: Inflammation | ||||||
| 10/01/2024 | Amgen Inc. | Otezla (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,100.00 | General |
| Category: Inflammation | ||||||
| 10/01/2024 | Amgen Inc. | Otezla (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $350.00 | General |
| Category: Inflammation | ||||||
About Dr. Brian Forrest, M.D
Dr. Brian Forrest, M.D is a Family Medicine healthcare provider based in Apex, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/07/2005. The National Provider Identifier (NPI) number assigned to this provider is 1376540112.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brian Forrest, M.D has received a total of $331,193 in payments from pharmaceutical and medical device companies, with $95,938 received in 2024. These payments were reported across 728 transactions from 19 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($249,583).
Ad
Practice Information
- Specialty Family Medicine
- Location Apex, NC
- Active Since 07/07/2005
- Last Updated 03/08/2011
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1376540112
Products in Payments
- Otezla (Drug) $284,118
- EUFLEXXA (Device) $37,069
- ELIQUIS (Drug) $8,172
- Ozempic (Drug) $334.92
- Skyrizi (Biological) $300.00
- Vascepa (Drug) $137.32
- Repatha (Biological) $121.17
- Livalo (Drug) $117.66
- MOUNJARO (Drug) $105.52
- TRULICITY (Drug) $89.37
- JANUVIA (Drug) $59.60
- FARXIGA (Drug) $43.86
- PREVNAR 20 (Biological) $43.72
- CAMZYOS (Drug) $42.08
- Saxenda (Drug) $39.12
- TOUJEO (Drug) $36.49
- Edarbyclor (Drug) $34.27
- VRAYLAR (Drug) $27.59
- Aimovig (Biological) $25.96
- INJECTAFER (Drug) $23.38
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Apex
Teneisha Davis, M.d, M.D
Family Medicine — Payments: $20,117
Family Medicine $20,117
Dr. Craig Stevens, Md, MD
Family Medicine — Payments: $3,675
Family Medicine $3,675
Dr. Ragini Madan, Md, MD
Family Medicine — Payments: $3,237
Family Medicine $3,237
Douglas Wadeson, Md, MD
Family Medicine — Payments: $2,497
Family Medicine $2,497
Mark Macpherson, D.o, D.O
Family Medicine — Payments: $2,159
Family Medicine $2,159
Dr. Maureen Dollinger, Md, MD
Family Medicine — Payments: $898.78
Family Medicine $898.78